Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture

This unit describes a technique for the direct and quantitative measurement of the capacity of peptide ligands to bind Class I and Class II MHC molecules. The binding of a peptide of interest to MHC is assessed based on its ability to inhibit the binding of a radiolabeled probe peptide to purified MHC molecules. This unit includes protocols for the purification of Class I and Class II MHC molecules by affinity chromatography, and for the radiolabeling of peptides using the chloramine T method. An alternate protocol describes alterations in the basic protocol that are necessary when performing direct binding assays, which are required for (1) selecting appropriate high‐affinity, assay‐specific, radiolabeled ligands, and (2) determining the amount of MHC necessary to yield assays with the highest sensitivity. After a predetermined incubation period, dependent upon the allele under examination, the bound and unbound radiolabeled species are separated, and their relative amounts are determined. Three methods for separation are described, two utilizing size‐exclusion gel‐filtration chromatography and a third using monoclonal antibody capture of MHC. Data analysis for each method is also explained. Curr. Protoc. Immunol. 100:18.3.1‐18.3.36. © 2013 by John Wiley & Sons, Inc.

[1]  J. Greenbaum,et al.  Dissecting Mechanisms of Immunodominance to the Common Tuberculosis Antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ) , 2012, The Journal of Immunology.

[2]  Søren Buus,et al.  Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. , 2011, Journal of immunological methods.

[3]  Bjoern Peters,et al.  Insights into HLA-Restricted T Cell Responses in a Novel Mouse Model of Dengue Virus Infection Point toward New Implications for Vaccine Design , 2011, The Journal of Immunology.

[4]  Bjoern Peters,et al.  A computational pipeline to generate MHC binding motifs , 2011, Immunome research.

[5]  Bjoern Peters,et al.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes , 2011, Immunogenetics.

[6]  Morten Nielsen,et al.  Peptide binding predictions for HLA DR, DP and DQ molecules , 2010, BMC Bioinformatics.

[7]  O. Lund,et al.  NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure , 2010, Immunome research.

[8]  Bjoern Peters,et al.  Divergent Motifs but Overlapping Binding Repertoires of Six HLA-DQ Molecules Frequently Expressed in the Worldwide Human Population , 2010, The Journal of Immunology.

[9]  Holger Becker,et al.  One size fits all? , 2010, Lab on a chip.

[10]  Morten Nielsen,et al.  MHC Class II epitope predictive algorithms , 2010, Immunology.

[11]  Bjoern Peters,et al.  Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass Allergen , 2010, The Journal of Immunology.

[12]  Bjoern Peters,et al.  Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage , 2010, Immunome research.

[13]  Bjoern Peters,et al.  Five HLA-DP Molecules Frequently Expressed in the Worldwide Human Population Share a Common HLA Supertypic Binding Specificity , 2010, The Journal of Immunology.

[14]  Alessandro Sette,et al.  The Immune Epitope Database 2.0 , 2009, Nucleic Acids Res..

[15]  J. Greenbaum,et al.  A Multivalent and Cross-Protective Vaccine Strategy against Arenaviruses Associated with Human Disease , 2009, PLoS pathogens.

[16]  John Sidney,et al.  Two MHC Class I Molecules Associated with Elite Control of Immunodeficiency Virus Replication, Mamu-B*08 and HLA-B*2705, Bind Peptides with Sequence Similarity12 , 2009, The Journal of Immunology.

[17]  Søren Buus,et al.  Functional recombinant MHC class II molecules and high-throughput peptide-binding assays , 2009, Immunome research.

[18]  M. Nielsen,et al.  Peptide Binding to HLA Class I Molecules: Homogenous, High-Throughput Screening, and Affinity Assays , 2009, Journal of biomolecular screening.

[19]  Markus Wulf,et al.  Identification of human MHC class I binding peptides using the iTOPIA- epitope discovery system. , 2009, Methods in molecular biology.

[20]  Vladimir Brusic,et al.  Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research , 2008, BMC Bioinformatics.

[21]  John Sidney,et al.  Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans , 2008, Journal of Virology.

[22]  Magdalini Moutaftsi,et al.  Dissociation between Epitope Hierarchy and Immunoprevalence in CD8 Responses to Vaccinia Virus Western Reserve1 , 2008, The Journal of Immunology.

[23]  John Sidney,et al.  A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach , 2008, PLoS Comput. Biol..

[24]  Bjoern Peters,et al.  Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.

[25]  O. Lund,et al.  NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.

[26]  V. Brusic,et al.  Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research , 2008, BMC Immunology.

[27]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[28]  Clemencia Pinilla,et al.  Characterization of the peptide-binding specificity of the chimpanzee class I alleles A*0301 and A*0401 using a combinatorial peptide library , 2007, Immunogenetics.

[29]  Bjoern Peters,et al.  A Quantitative Analysis of the Variables Affecting the Repertoire of T Cell Specificities Recognized after Vaccinia Virus Infection1 , 2007, The Journal of Immunology.

[30]  Bjoern Peters,et al.  The CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus Involves the L Antigen: Uncovering New Tricks for an Old Virus , 2007, Journal of Virology.

[31]  Magdalini Moutaftsi,et al.  A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.

[32]  Morten Nielsen,et al.  A Community Resource Benchmarking Predictions of Peptide Binding to MHC-I Molecules , 2006, PLoS Comput. Biol..

[33]  Bjoern Peters,et al.  HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. , 2005, The Journal of Immunology.

[34]  F. Tödtling,et al.  One size fits all?: Towards a differentiated regional innovation policy approach , 2005 .

[35]  Bjoern Peters,et al.  HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Wilfried Bardet,et al.  Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery. , 2005, Biochemistry.

[37]  Bjoern Peters,et al.  Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications , 2005, Immunogenetics.

[38]  Wilfried Bardet,et al.  Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization. , 2004, Biochemistry.

[39]  S Brunak,et al.  SARS CTL Vaccine Candidates — HLA Supertype, Genome‐Wide Scanning and Biochemical Validation , 2004, Tissue antigens.

[40]  S. Brunak,et al.  SARS CTL vaccine candidates; HLA supertype‐, genome‐wide scanning and biochemical validation , 2004, Tissue antigens.

[41]  Hans-Georg Rammensee,et al.  MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.

[42]  John Sidney,et al.  Simultaneous Prediction of Binding Capacity for Multiple Molecules of the HLA B44 Supertype 1 , 2003, The Journal of Immunology.

[43]  C. Sylvester-Hvid,et al.  Purification of correctly oxidized MHC class I heavy‐chain molecules under denaturing conditions: A novel strategy exploiting disulfide assisted protein folding , 2003, Protein science : a publication of the Protein Society.

[44]  S L Lauemøller,et al.  Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction. , 2002, Tissue antigens.

[45]  Craig Beeson,et al.  Binding interactions between peptides and proteins of the class II Major Histocompatibility Complex , 2002, Medicinal research reviews.

[46]  D Rognan,et al.  Use of fluorescence polarization to monitor MHC-peptide interactions in solution. , 2001, Journal of immunological methods.

[47]  S Brunak,et al.  Quantitative predictions of peptide binding to MHC class I molecules using specificity matrices and anchor-stratified calibrations. , 2001, Tissue antigens.

[48]  Taku Suto,et al.  An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries , 2000, Immunogenetics.

[49]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[50]  Todd M. Allen,et al.  Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. , 1998, Journal of immunology.

[51]  M F del Guercio,et al.  Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.

[52]  Hans-Georg Rammensee,et al.  MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.

[53]  A Sette,et al.  Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.

[54]  John Sidney,et al.  Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes , 1997, Immunogenetics.

[55]  M F del Guercio,et al.  Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. , 1996, Journal of immunology.

[56]  Søren Buus,et al.  Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding , 1996, European journal of immunology.

[57]  G. Nepom,et al.  Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M F del Guercio,et al.  Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. , 1996, Human immunology.

[59]  M F del Guercio,et al.  Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules. , 1995, Journal of immunology.

[60]  S. Kienle,et al.  Decrypting the structure of major histocompatibility complex class I- restricted cytotoxic T lymphocyte epitopes with complex peptide libraries , 1995, The Journal of experimental medicine.

[61]  S. Buus,et al.  Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method. , 1995, Biochimica et biophysica acta.

[62]  J. Hammer,et al.  New methods to predict MHC-binding sequences within protein antigens. , 1995, Current opinion in immunology.

[63]  G Hermanson,et al.  Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. , 1995, Journal of immunology.

[64]  M F del Guercio,et al.  Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.

[65]  D. Madden.  The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.

[66]  C Oseroff,et al.  Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. , 1994, Immunity.

[67]  Z. Nagy,et al.  Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.

[68]  J. Sidney,et al.  Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. , 1994, Molecular immunology.

[69]  J. Rothbard.  Antigen Presentation: One size fits all , 1994, Current Biology.

[70]  C Oseroff,et al.  HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs. , 1994, Journal of immunology.

[71]  J. Rothbard,et al.  Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. , 1994, Journal of immunology.

[72]  M F del Guercio,et al.  Definition of a DQ3.1-specific binding motif. , 1994, Journal of immunology.

[73]  R. Henderson,et al.  Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. , 1994, Science.

[74]  D. Wiley,et al.  Antigenic peptide binding by class I and class II histocompatibility proteins. , 1994, Structure.

[75]  J. Rothbard,et al.  Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. , 1994, Journal of immunology.

[76]  Søren Buus,et al.  A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules , 1994, European journal of immunology.

[77]  F. Sinigaglia,et al.  Defining rules for the peptide-MHC class II interaction. , 1994, Current opinion in immunology.

[78]  S. Nathenson,et al.  Methods to study peptides associated with MHC class I molecules. , 1994, Current opinion in immunology.

[79]  O. Rötzschke,et al.  Origin, structure and motifs of naturally processed MHC class II ligands. , 1994, Current opinion in immunology.

[80]  Ronald N. Germain,et al.  MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.

[81]  V. Engelhard,et al.  Structure of peptides associated with class I and class II MHC molecules. , 1994, Annual review of immunology.

[82]  K. Parker,et al.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.

[83]  N. Suciu-Foca,et al.  Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs. , 1993, Journal of immunology.

[84]  M F del Guercio,et al.  HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. , 1993, Journal of immunology.

[85]  J. Sidney,et al.  Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.

[86]  D. Margulies,et al.  Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity. , 1993, The Journal of biological chemistry.

[87]  F. Sinigaglia,et al.  Promiscuous and allele-specific anchors in HLA-DR-binding peptides , 1993, Cell.

[88]  P. Parham,et al.  Peptide binding to major histocompatibility complex molecules. , 1993, Annual review of cell biology.

[89]  R. Germain,et al.  The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.

[90]  R A Houghten,et al.  Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. , 1992, BioTechniques.

[91]  J. Sidney,et al.  DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles. , 1992, Journal of immunology.

[92]  K. Parker,et al.  The beta 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound. , 1992, Journal of immunology.

[93]  D. Wettstein,et al.  pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. , 1992, The EMBO journal.

[94]  H. Grey,et al.  Chemistry of peptide interactions with MHC proteins , 1992, Current Biology.

[95]  D. Margulies,et al.  Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[96]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[97]  J. Sidney,et al.  Effect of pH on MHC class II-peptide interactions. , 1992, Journal of immunology.

[98]  C Oseroff,et al.  On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. , 1991, Journal of immunology.

[99]  Timothy E. Elliott,et al.  The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules , 1991, European journal of immunology.

[100]  M. Luscher,et al.  Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis , 1991, Nature.

[101]  J. Rothbard,et al.  Conformational and structural characteristics of peptides binding to HLA-DR molecules. , 1991, Journal of immunology.

[102]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[103]  S. Nathenson,et al.  Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.

[104]  R W Chesnut,et al.  Characterization of the specificity of peptide binding to four DR haplotypes. , 1990, Journal of immunology.

[105]  J. Sidney,et al.  A novel approach to the generation of high affinity class II-binding peptides. , 1990, Journal of immunology.

[106]  Hidde L. Ploegh,et al.  Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro , 1990, Cell.

[107]  Hidde L. Ploegh,et al.  Empty MHC class I molecules come out in the cold , 1990, Nature.

[108]  T. Elliott,et al.  Assembly of MHC class I molecules analyzed in vitro , 1990, Cell.

[109]  J. Rothbard,et al.  Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. , 1990, International immunology.

[110]  H. Grey,et al.  The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo. , 1990, Journal of immunology.

[111]  P. Cresswell,et al.  High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. , 1990, Journal of immunology.

[112]  Antonio Lanzavecchia,et al.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.

[113]  G. Ferrara,et al.  Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells , 1989, Nature.

[114]  G. Otten.  Antigen processing and presentation. , 1989, Current opinion in immunology.

[115]  A. Trzeciak,et al.  A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules , 1988, Nature.

[116]  H. Grey,et al.  Autologous peptides constitutively occupy the antigen binding site on Ia. , 1988, Science.

[117]  A Sette,et al.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides , 1987, Science.

[118]  H. Grey,et al.  Isolation and characterization of antigen-la complexes involved in T cell recognition , 1986, Cell.

[119]  H. Grey,et al.  Isolation and characterization of antigen-Ia complexes involved in T cell recognition. , 1986, Cell.

[120]  C. Janeway,et al.  Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. , 1984, Journal of immunology.

[121]  B. Malissen,et al.  Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. , 2008, Tissue antigens.

[122]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[123]  C. Hawker.  Radioimmunoassay and related methods , 1973 .

[124]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.